Fri, November 19, 2021

Do Kim Initiated (ABCL) at Buy and Held Target at $33 on, Nov 19th, 2021

Do Kim of Piper Sandler, Initiated "AbCellera Biologics Inc." (ABCL) at Buy and Held Target at $33 on, Nov 19th, 2021.

Do has made no other calls on ABCL in the last 4 months.



There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Do's Rating of Hold.



This is the rating of the analyst that currently disagrees with Do


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $49 on, Friday, August 13th, 2021